Creative Peptides Adds an Exclusive Section for Cancer Research
LONG ISLAND CITY, NY, UNITED STATES - Jul 17, 2019 - As one of the global leading peptide suppliers, Creative Peptides announced to add an exclusive section of peptides for researchers who are committed to exploring an effective solution for issues related to cancer research.
Cancer, featured by abnormal cell growth with the potential to invade or spread into other parts of the body, has now become the top one killer for human death among all diseases. Although chemotherapy and radiation therapy have already been widely used in cancer treatment, no effective cure with fewer side effects has been found. In the past few decades, peptides therapeutics began to bring a new hope for cancer therapy.
"Recent study proves that peptides are actually promising reagents in cancer research for early diagnosis, prognostic predictors, and the treatment of cancer patients. In comparison with other therapies, peptides possess unique properties, making them superior in cancer research. For example, peptide vaccine has attracted increased attention from the scientists for their potentials to be used as anticancer drugs," says Dr. Robert Martinez, spokesperson from Creative Peptides.
Conventional chemotherapeutic drugs have significant limitations. They may hurt normal cells while they destroy cancer cells by chemoresistance mechanisms. Therefore, it would be great to find a way to selectively target and kill cancer cells. A growing number of studies indicate that peptides may be ideal candidates for cancer treatment as they have minimal immunogenicity, low-cost manufacturability, excellent tissue penetrability, and ease of modification. All could help enhance in vivo stability and biological activity.
"Generally speaking, three major peptides are involved in cancer therapies. The first group are those naturally occurred peptides or peptides derived from a known protein, which possess inherent membrane binding capacity to form pores or disrupt membranes, such as cecropins and magainins. The second group are cell penetrating peptides, such as the TAT from HIV. The third are comprised of tumor targeting peptides, such as G-protein-coupled receptors," Dr. Martinez.continues to explain.
Other peptides are also accessible at Creative Peptides, including: checkpoint inhibitors, fibronectin fragments, luteinizing hormone-releasing hormone and analogs, matrix metalloproteinase inhibitors, growth factors and analogs, melanoma peptide sequences, somatostatin & analogs, and more.
To know more about peptides exclusively offered for cancer research, please visit: https://www.creative-peptides.com/research-areas/cancer-research.html.
About Creative Peptides
With over a dozen of years' experience in peptide manufacturing and synthesis, Creative Peptides has now gained a fame in custom peptide synthesis, stapled peptide synthesis, GMP manufacturing, peptide drug discovery as well as supplying API peptides, cosmetic peptides, catalog peptides, cell penetrating peptides, etc.